ADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States.

The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery.

This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners.

The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.